Cardiolyse media kit.
Everything you need to write about Cardiolyse — logos, brand assets, company factsheet, approved boilerplate and press contact. If you need something you can't find here, get in touch.
Brand assets
Logos.
Please use the official Cardiolyse wordmark and icon in unmodified form. Keep clear space around the logo equal to the height of the icon, and don't recolour, rotate, distort or add effects.
Wordmark — Black
For use on white and light-cream backgrounds. Preferred lockup for print and press.
Wordmark — White
For use on navy, black and photographic backgrounds with enough contrast.
Wordmark — Brand Blue
Colour version for digital use on light backgrounds where a monochrome mark is too flat.
Icon — Black
App and favicon mark for light backgrounds. Use only where the wordmark can’t fit.
About the company
Boilerplate.
Approved short and long descriptions for use in press releases, articles and partner materials. Please use these versions verbatim — get in touch if you need a translation or a variant.
Short (33 words)
Cardiolyse delivers AI-powered ECG analytics for screening and precision medicine. Its CE Class IIa certified software automates ECG interpretation, identifies high-risk patients and supports precision cardiology workflows — device-agnostic, API-first and built in Helsinki.
Long (135 words)
Cardiolyse is a Helsinki-based health-tech company delivering AI-powered ECG analytics for screening and precision medicine. Its software automates ECG interpretation, identifies high-risk patients and supports precision cardiology workflows across resting ECG, Holter ECG and ECG digitalisation. The platform works with any ECG source — 12-lead hospital devices, Holter monitors, home-use devices and wearables — detects 30+ arrhythmias and heart abnormalities, and extracts 300 vital ECG parameters per recording, delivering clinician-ready reports that can be reviewed, adjusted and signed. Built on more than a decade of clinical R&D and over 1 million ECGs analysed, Cardiolyse is CE-marked as Class IIa medical device software under EU Regulations, with ISO 13485 quality management and ISO 27001-aligned information security. It serves healthcare providers, device manufacturers, and clinical-trial sponsors and research groups, and is headquartered at Terkko Health Hub in Helsinki.
Company factsheet
Quick facts.
- Company
- Cardiolyse Oy
- Registration number
- 2773211-3
- Headquarters
- Terkko Health Hub, Haartmaninkatu 4, 00290 Helsinki, Finland
- CEO
- Normunds Daudiss
- What we do
- AI-powered ECG analytics for screening and precision medicine — resting ECG, Holter ECG and ECG digitalisation; device-agnostic and API-first
- Regulatory status
- CE-marked Class IIa medical device software under EU Regulations; ISO 13485 quality management; ISO 27001-aligned information security
- Website
- cardiolyse.com
- linkedin.com/company/cardiolyse
Press & partnerships
Get in touch.
Reach out for interviews, expert commentary, product screenshots or executive photography.
Press & media
Media inquiries
Interviews, quotes, briefings and expert commentary on AI-powered ECG analytics.
Partnerships
Business development
Device integrations, clinical collaborations, pharma trials and co-marketing.